RCEL Stock Analysis: Buy, Sell, or Hold?
RCEL - Avita Medical, Inc. Common Stock
$4.41
0.05 (1.15%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 12, 2026
11d
Get Alerted When RCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RCEL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: RCEL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: RCEL is currently trading at $4.41, which is considered extended relative to its 30-day fair value range of $3.30 to $4.18.
Technical Outlook: Technically, RCEL is in a downtrend. Immediate support is located at $3.47, while resistance sits at $4.57.
Market Sentiment: RCEL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $7.38 (+69.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RCEL is in a downtrend. Immediate support is located at $3.47, while resistance sits at $4.57.
Market Sentiment: RCEL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $7.38 (+69.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$3.30 -
$4.18
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range (+5.5% above fair value)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 69.2% below Wall St target ($7.38)
Fair Price Analysis
30-Day Fair Range
$3.30 -
$4.18
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$0.73
(16.6%)
Support & Resistance Levels
Support Level
$3.47
Resistance Level
$4.57
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.03
Wall Street Target
$7.38
(+69.2%)
Revenue Growth (YoY)
-12.7%
Profit Margin
-67.1%
Last updated: January 31, 2026 12:05 AM ET
Data refreshes hourly during market hours. Next update: 1:05 AM
Data refreshes hourly during market hours. Next update: 1:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RCEL showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Robert Mcnamara
BUY
10000 shares
2025-08-28
David D O'toole
BUY
2000 shares
2025-08-26
Robert Mcnamara
BUY
10000 shares
2025-08-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
Advanced RCEL Option Strategies
Professional options setups generated by AI based on today's RCEL price and gamma walls.
